Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis

Area of Science:

• Genetics and Molecular Biology
• Gastroenterology
• Immunology

Background:

• Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a group of chronic gastrointestinal disorders with complex etiologies.
• Genetic factors, including variations in the CD24 gene, are increasingly recognized as potential contributors to IBD susceptibility.

Purpose of the Study:

• To investigate the association between CD24 gene polymorphisms and the risk of developing IBD, specifically UC and CD.
• To evaluate two common CD24 polymorphisms: C170T (rs8734) and TG1527del (rs3838646).

Main Methods:

• A systematic literature search was conducted across PubMed, Web of Science, and Cochrane Library databases up to May 30, 2014.
• Eligible studies were case-control in design, focusing on CD24 gene variants and IBD risk, with data extracted independently by two investigators.
• Statistical analysis using Stata SE12 calculated pooled odds ratios (ORs) and 95% confidence intervals (CIs) for identified polymorphisms.

Main Results:

• The meta-analysis included three case-control studies with 2342 IBD patients and 1965 healthy controls, all from Caucasian cohorts.
• No significant overall association was found between the two CD24 polymorphisms and the general risk of IBD (P > 0.05).
• Subgroup analysis revealed that the CD24 C170T polymorphism was linked to an increased risk of UC (dominant and additive models, P < 0.05), while the TG1527del polymorphism was associated with CD risk in the additive model (P = 0.037).

Conclusions:

• The CD24 C170T polymorphism may play a role in the susceptibility to ulcerative colitis.
• The CD24 TG1527del polymorphism appears to be associated with an increased risk of Crohn's disease.